| Oct 9 |
Dyadic International Inc (DYAI) Q2 2024 Earnings Call Highlights: Strategic Positioning Amid ...
|
| Oct 9 |
Dyadic Expands Global Presence with Participation in Key Industry Events
|
| Sep 23 |
Dyadic Provides Alternative Proteins Business Update and Announces Attendance at Bioprocess International Conference
|
| Aug 14 |
Dyadic International, Inc. (DYAI) Q2 2024 Earnings Call Transcript
|
| Aug 13 |
Dyadic International GAAP EPS of -$0.07 in-line, revenue of $385.89M beats by $384.89M
|
| Aug 13 |
Dyadic Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress
|
| Jul 30 |
Dyadic to Report Second Quarter 2024 Financial Results on Tuesday, August 13, 2024
|
| Jul 1 |
DYAI: Moo-ve Over Bovines, C1's Taking On Albumin
|
| Jun 28 |
Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership
|
| May 30 |
Dyadic to Attend Industry Events in June
|
